1204 Epigenetics and Methylomics in Psychiatry. Stephen M. Stahl
1206 Intervention in Individuals at Ultra-High Risk for Psychosis: A Review and Future Directions.
1213 Relations Among Psychopathology, Substance Use, and Physical Pain Experiences in Methadone-Maintained Patients. [CME]
1219 Adding Psychotherapy to Pharmacotherapy in the Treatment of Depressive Disorders in Adults: A Meta-Analysis.
1230 A Model of the Economic Impact of a Bipolar Disorder Screening Program in Primary Care.
1237 Three-Year Follow-Up of Syndromal Antisocial Behavior in Adults: Results From the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions. [CME]
1250 A Cross-Sectional Study of Problem and Pathological Gambling in Patients With Schizophrenia/Schizoaffective Disorder.
1258 Cutaneous Adverse Reactions to Psychotropic Drugs: Data From a Multicenter Surveillance Program.
1266 Association Between Number of Deployments to Iraq and Mental Health Screening Outcomes in US Army Soldiers.
1273 Mood Stabilization and Destabilization During Acute and Continuation Phase Treatment for Bipolar I Disorder With Lamotrigine or Placebo.
1281 Association of Adverse Childhood Environment and 5-HTTLPR Genotype With Late-Life Depression.
Focus on Women's Mental Health
1289 Perinatal Mental Health: New Data Regarding Risk Factors and Treatment Considerations.
1290 Prepregnancy Body Mass Index, Gestational Weight Gain, and the Likelihood of Major Depressive Disorder During Pregnancy.
1297 Prenatal Care and Adverse Pregnancy Outcomes Among Women With Schizophrenia: A Nationwide Population-Based Study in Taiwan.
1304 Venlafaxine in Human Breast Milk and Nursing Infant Plasma: Determination of Exposure.
Perspectives on Perinatal Depression Treatment
Note: To allow all our users to participate in the forum, the full text of each of the following commentaries is available to registered users via the Forum link.
1311 Perinatal Psychiatry: The Challenges of Making Rational Treatment Decisions at the Interface of Psychiatry and Obstetrics.
1313 Influence of the Media on Women Taking Antidepressants During Pregnancy.
1314 The Other Side of the Risk Equation: Exploring Risks of Untreated Depression and Anxiety in Pregnancy.
1315 Reflections on Perinatal Depression Treatment.
1316 Do We Scare Because We Care?
1317 Perinatal Depression: Searching for Specific Tools for a Closer Look at This Window.
1318 Psychotherapeutic Treatment Options for Perinatal Depression: Emphasis on Maternal-Infant Dyadic Outcomes.
1319 No Decision Is Without Risk.
1320 The Cost of Restricting Knowledge.
1321 Pharmacotherapy or Untreated Antenatal Depression: A False Dichotomy.
1323 Genetic Studies of Drug Response and Side Effects in the STAR*D Study, Part 2.
Letters To the Editor
1326 Melancholia as a Useful Subtype of Major Depression.
1326 Activation Induced by High-Dose Ziprasidone: A Case Report.
1327 How Should Research Productivity Be Assessed in Early Career Psychiatric Researchers? Research Funding Versus Scientific Productivity.
• Reply by Joseph F. Goldberg
1328 Effect of Anxiety Symptoms on Adherence to Highly Active Antiretroviral Therapy in HIV-Infected Women.
1330 Autism Spectrum Disorders in Infants and Toddlers: Diagnosis, Assessment, and Treatment.
1330 Current Diagnosis & Treatment: Psychiatry, 2nd ed.
1331 Suicide Among Racial and Ethnic Minority Groups: Theory, Research, and Practice.
1331 Clinical Manual of Child and Adolescent Psychopharmacology.
online CME Activities
e31 Treating Partial Responders to Antidepressant Treatment.
e32 Diagnosis and Impact of Bipolar Depression.
e33 Newer Medications for Complicated Depression.
e34 Treatment Options for Children and Adolescents With Bipolar Disorder.
e35 Postpartum Depression Treatment and Breastfeeding.